EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Cantharidin (1%), podophyllin (5%), and salicylic acid (30%) formulation in recalcitrant plantar warts: Analysis of 48 patients

Jéssica Amo-Navarrete iD, Sara García-Oreja iD, Diego León-Herce iD, David Navarro-Pérez iD, José Luís Lázaro-Martínez iD, Francisco Javier Álvaro-Afonso iD

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.29925 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Jéssica Amo-Navarrete und 5 weiteren Autor:innen. Beteiligte Einrichtung: University Podiatric Clinic, Complutense University of Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: Cantharidin, Podophyllin, Salicylic Acid, Warts. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A plantar wart is a benign hyperplasia that appears on the feet due to the human papillomavirus (HPV). One method used for the treatment of recalcitrant plantar warts, those lasting over 2 years or persisting after at least two treatment attempts, is the cantharidin (1%), podophyllin (5%), and salicylic acid (30%) formulation, also known as the CPS formulation. Although this method is in use, there are few studies on it. This study's objective was to ascertain its cure rate. For this retrospective observational study, we reviewed the medical records of patients treated with the CPS formulation at a podiatric clinic specializing in plantar wart treatment. Our sample size was 48 subjects. The CPS formulation had a cure rate of 62.5%. Out of the cured patients, 86.67% (26/30) required one or two applications. There was no observable correlation ( p > 0.05) between wart resolution and virus biotype, evolution time, patient's morphological and clinical attributes, location, number of warts, or preceding treatments. The CPS formulation presents a relatively high efficacy rate for treating recalcitrant HPV plantar warts. Still, additional studies are necessary to evaluate its safety and efficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CantharidinPodophyllinSalicylic AcidWartsAdolescentAdultFemaleHumansMaleMiddle AgedYoung AdultRetrospective StudiesTreatment OutcomeDrug CombinationsAged

Stichwörter der Autor:innen

HPVcantharidinhuman papillomavirusplantar wartsrecalcitrant

Substanzen

CantharidinPodophyllinSalicylic AcidDrug Combinations

Autor:innen und Institutionen

  • University Podiatric Clinic, Complutense University of Madrid, Madrid, Spain.
  • Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), University Podiatric Clinic, Complutense University of Madrid, Madrid, Spain.

ORCID-Profile: Jéssica Amo-Navarrete, Sara García-Oreja, Diego León-Herce, David Navarro-Pérez, José Luís Lázaro-Martínez, Francisco Javier Álvaro-Afonso

Zitieren

APA

Amo-Navarrete, J., García-Oreja, S., León-Herce, D., Navarro-Pérez, D., Lázaro-Martínez, J. L., & Álvaro-Afonso, F. J. (2024). Cantharidin (1%), podophyllin (5%), and salicylic acid (30%) formulation in recalcitrant plantar warts: Analysis of 48 patients. Journal of Medical Virology. https://doi.org/10.1002/jmv.29925

Vancouver

Amo-Navarrete J, García-Oreja S, León-Herce D, Navarro-Pérez D, Lázaro-Martínez JL, Álvaro-Afonso FJ. Cantharidin (1%), podophyllin (5%), and salicylic acid (30%) formulation in recalcitrant plantar warts: Analysis of 48 patients. Journal of Medical Virology. 2024. doi:10.1002/jmv.29925

BibTeX
@article{AmoNavarrete2024,
  author = {Amo-Navarrete, Jéssica and García-Oreja, Sara and León-Herce, Diego and Navarro-Pérez, David and Lázaro-Martínez, José Luís and Álvaro-Afonso, Francisco Javier},
  title = {Cantharidin (1%), podophyllin (5%), and salicylic acid (30%) formulation in recalcitrant plantar warts: Analysis of 48 patients},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.29925}
}
Kostenlos starten →